
CavaGene is a cancer diagnostics company that aims to transform cancer care through the integration of advanced Artificial Intelligence (AI) and genomics. The company focuses on making early detection and personalized treatment universally accessible using secure, saliva-based genomic data for non-invasive diagnostics, initially for breast cancer and expanding to other cancers. Their technology leverages cutting-edge AI, including Retrieval-Augmented Generation (RAG) in Natural Language Processing (NLP) and Large Multimodal Model (LMM)-based agents with an agentic orchestration layer of LangChain. CavaGene's mission supports global public health by addressing social determinants, health equity, and information disparities. They offer non-invasive home-kit diagnostics and lab-based diagnostics, alongside AI-driven personalized treatment plans.

CavaGene is a cancer diagnostics company that aims to transform cancer care through the integration of advanced Artificial Intelligence (AI) and genomics. The company focuses on making early detection and personalized treatment universally accessible using secure, saliva-based genomic data for non-invasive diagnostics, initially for breast cancer and expanding to other cancers. Their technology leverages cutting-edge AI, including Retrieval-Augmented Generation (RAG) in Natural Language Processing (NLP) and Large Multimodal Model (LMM)-based agents with an agentic orchestration layer of LangChain. CavaGene's mission supports global public health by addressing social determinants, health equity, and information disparities. They offer non-invasive home-kit diagnostics and lab-based diagnostics, alongside AI-driven personalized treatment plans.